News

Facility was expanded to accommodate new GMP manufacturing suites and onsite packaging line for larger scale production and cost reduction. Elite chairman and CEO Jerry Treppel said, "Shipping

According to the deal, GVK BIO will deliver a clinical candidate while Endo is responsible for the development and commercialization of the resulting product. GVK BIO CEO Manni

The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North Carolina at Chapel Hill, and The University of Texas Southwestern Medical Center jointly own the patent

The collaboration will focus on evaluating MCHC’s closed hydroponic cultivation system, plant factory system, developed to grow plants. Medicago’s technologies will be used to produce Nicotiana Benthamiana plants

The $20m new eco-friendly building plant provides space for two new cleanrooms for filter and bag manufacture, labs and offices. Using harvested rainwater and air-handling unit condensate for

The Centricity Practice Solution 11 solution, which features a dynamic search engine, simplifies the data entry required for ambulatory practices to comply with new the ICD-10 coding requirements

Various studies demonstrated a woman’s ability to recognize OAB symptoms, understand vital safety information on the label, judge the necessity of the product use and fittingly use Oxytrol

European patent covers a chemical structure and new chemical process of the chemistry platform technology, developed for therapeutic and cosmetic purpose. Sirona Biochem chief executive officer Neil Belenkie

Desloratadine ODT is a generic equivalent to Clarinex Reditabs (desloratadine), which according to IMS Health data had total sales of $5.3m in the US for the twelve months